Acadian Asset Management’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $369K | Sell |
20,421
-2,606
| -11% | -$47.1K | ﹤0.01% | 1200 |
|
2025
Q1 | $219K | Buy |
23,027
+6,823
| +42% | +$64.9K | ﹤0.01% | 1242 |
|
2024
Q4 | $255K | Buy |
16,204
+2,646
| +20% | +$41.6K | ﹤0.01% | 1215 |
|
2024
Q3 | $203K | Hold |
13,558
| – | – | ﹤0.01% | 1353 |
|
2024
Q2 | $184K | Buy |
13,558
+7,690
| +131% | +$104K | ﹤0.01% | 1441 |
|
2024
Q1 | $78K | Hold |
5,868
| – | – | ﹤0.01% | 1322 |
|
2023
Q4 | $57K | Sell |
5,868
-1,088
| -16% | -$10.6K | ﹤0.01% | 1444 |
|
2023
Q3 | $73K | Sell |
6,956
-2,532
| -27% | -$26.6K | ﹤0.01% | 1362 |
|
2023
Q2 | $130K | Sell |
9,488
-3,641
| -28% | -$49.9K | ﹤0.01% | 1354 |
|
2023
Q1 | $132K | Sell |
13,129
-8,296
| -39% | -$83.4K | ﹤0.01% | 1339 |
|
2022
Q4 | $332K | Sell |
21,425
-2,721
| -11% | -$42.2K | ﹤0.01% | 1148 |
|
2022
Q3 | $474K | Sell |
24,146
-22,500
| -48% | -$442K | ﹤0.01% | 1002 |
|
2022
Q2 | $1.18M | Sell |
46,646
-30,638
| -40% | -$772K | 0.01% | 780 |
|
2022
Q1 | $1.91M | Sell |
77,284
-56,779
| -42% | -$1.4M | 0.01% | 679 |
|
2021
Q4 | $3.75M | Buy |
134,063
+16,336
| +14% | +$456K | 0.01% | 524 |
|
2021
Q3 | $4.91M | Sell |
117,727
-12,844
| -10% | -$536K | 0.02% | 450 |
|
2021
Q2 | $6.08M | Buy |
130,571
+41,527
| +47% | +$1.93M | 0.02% | 422 |
|
2021
Q1 | $4.92M | Buy |
89,044
+31,809
| +56% | +$1.76M | 0.02% | 484 |
|
2020
Q4 | $4.15M | Buy |
57,235
+54,232
| +1,806% | +$3.94M | 0.02% | 549 |
|
2020
Q3 | $593K | Buy |
+3,003
| New | +$593K | ﹤0.01% | 1079 |
|
2018
Q4 | – | Sell |
-80
| Closed | -$36K | – | 1714 |
|
2018
Q3 | $36K | Hold |
80
| – | – | ﹤0.01% | 1428 |
|
2018
Q2 | $38K | Buy |
80
+26
| +48% | +$12.4K | ﹤0.01% | 1446 |
|
2018
Q1 | $32K | Sell |
54
-62
| -53% | -$36.7K | ﹤0.01% | 1431 |
|
2017
Q4 | $63K | Sell |
116
-2,186
| -95% | -$1.19M | ﹤0.01% | 1190 |
|
2017
Q3 | $965K | Buy |
2,302
+941
| +69% | +$394K | ﹤0.01% | 689 |
|
2017
Q2 | $338K | Buy |
1,361
+501
| +58% | +$124K | ﹤0.01% | 886 |
|
2017
Q1 | $263K | Buy |
860
+506
| +143% | +$155K | ﹤0.01% | 1000 |
|
2016
Q4 | $52K | Buy |
+354
| New | +$52K | ﹤0.01% | 1176 |
|